References
- Czerwinski M, Buckley DB, Kazmi F. (2012). In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes. U.S. Patent 8,846,576.
- Drug Metabolism Discussion Group (DMDG). Available from: www.dmdg.org [last accessed 7 Feb 2020].
- Schmitt C, Kuhn B, Zhang X, et al. (2011). Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis. Clin Pharmacol Ther 89:735–40.
- US Food and Drug Administration (FDA). (2012). Draft guidance, Drug Interaction Studies – Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations, no URLlink available as guidance has been removed [last accessed 7 Feb 2020].
- US Food and Drug Administration (FDA). (2017). Draft guidance, In Vitro Metabolism- and Transporter- Mediated Drug-Drug Interaction Studies, no URLlink available as guidance has been removed [last accessed 7 Feb 2020].
- US Food and Drug Administration (FDA). Framework for Assessment of Drug-Drug Interactions for Therapeutic Proteins; Establishment of a Public Docket; Request for Information and Comments (Docket FDA-2018-N-1415). Available from: www.federalregister.gov/documents/2018/05/10/2018-09931/framework-for-assessment-of-drug-drug-interactions-for-therapeutic-proteins-establishment-of-a [last accessed 7 Feb 2020].